Europe
Bactiquant A/S Rights Issue and Trading Admission
• Bactiquant A/S has announced a rights issue and admission to trading of subscription rights.
• The rights issue will be admitted to trading on Nasdaq First North Growth Market Denmark as of 13 January 2025.
• The rights issue will allow Bactiquant A/S to trade its subscription rights on the stock exchange.
• The rights issue is part of the company’s strategy to diversify its portfolio and increase its market share.
• The company’s shares will be listed on the Copenhagen Stock Exchange.
